- Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
- Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
- Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
- Asahi Kasei to Highlight Sustainability, 3D Printing Filaments, Purging Compounds, and More at NPE 2024
- Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan
- ZOLL Receives Innovative Technology Contract from Vizient for TherOx SuperSaturated Oxygen (SSO2) Therapy
- Asahi Kasei Bioprocess’ Massachusetts Training Center Expands 2024 Course Offerings for Career Development and Industry Training
- Senseair Releases New Module, S88, for Advanced CO2 Monitoring
- Asahi Kasei Microdevices’ New Current Sensor Enables Dramatically Smaller On-Board Chargers for Electric Vehicles
- Asahi Kasei Offers Pharmaceutical Excipient Ceolus™ with Nitrite Concentration of 0.1 ppm or Less
More ▼
Key statistics
As of last trade Asahi Kasei Corp (AHKSY:PNK) traded at 14.33, -7.90% below its 52-week high of 15.56, set on Jan 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.28 |
---|---|
High | 14.39 |
Low | 14.28 |
Bid | -- |
Offer | -- |
Previous close | 14.33 |
Average volume | 23.37k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.5019 USD |
---|---|
Annual div yield (ADY) | 3.50% |
Div ex-date | Sep 27 2023 |
Div pay-date | Dec 18 2023 |
Data delayed at least 15 minutes, as of May 07 2024 15:22 BST.
More ▼